R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis

[1]  F. Houssiau,et al.  Cytokines in rheumatoid arthritis , 1995, Clinical Rheumatology.

[2]  H. G. Eijk,et al.  Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis , 1992, Annals of Hematology.

[3]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. , 1993, The Journal of clinical investigation.

[4]  Á. Remacha,et al.  Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin. , 1992, The Journal of rheumatology.

[5]  B. Löwenberg,et al.  Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis , 1992, European journal of clinical investigation.

[6]  W. Jelkmann,et al.  Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. , 1992, Life sciences.

[7]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. , 1991, Blood.

[8]  T. Lappin,et al.  Evidence for impaired erythropoietin response to anaemia in rheumatoid disease. , 1991, British journal of rheumatology.

[9]  C. Salvarani,et al.  The role of interleukin 1, erythropoietin and red cell bound immunoglobulins in the anaemia of rheumatoid arthritis. , 1991, Clinical and experimental rheumatology.

[10]  G. Birgegard,et al.  Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin. , 1991, Contributions to nephrology.

[11]  B. Löwenberg,et al.  Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. , 1991, Leukemia.

[12]  T. Schnitzer,et al.  Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. , 1990, The American journal of medicine.

[13]  E. Dessypris,et al.  Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. , 1990, The Journal of clinical investigation.

[14]  P. Furmanski,et al.  Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor. , 1990, Blood.

[15]  C. Maury,et al.  Correlation of serum cytokine levels with haematological abnormalities in human immunodeficiency virus infection , 1990, Journal of internal medicine.

[16]  P. Furmanski,et al.  In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). , 1990, Experimental hematology.

[17]  A. Swaak,et al.  Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. , 1990, Annals of the rheumatic diseases.

[18]  J. Caro,et al.  Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. , 1989, Blood.

[19]  T. Pincus,et al.  Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. , 1989, Arthritis and rheumatism.

[20]  M. Feldmann.  Molecular mechanisms involved in human autoimmune diseases: relevance of chronic antigen presentation. Class II expression and cytokine production. , 1989, Immunology. Supplement.

[21]  M. Turner,et al.  Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. , 1988, Clinical and experimental immunology.

[22]  G. Roodman,et al.  Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. , 1987, Experimental hematology.

[23]  M. Kawakami,et al.  Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells. , 1987, International journal of cell cloning.

[24]  J. Saklatvala.  Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage , 1986, Nature.

[25]  D. Williams,et al.  The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. , 1986, Journal of immunology.

[26]  B. Beutler,et al.  Brief Definitive Report Cachectin/tumor Necrosis Factor Stimulates Collagenase and Prostaglandin E2 Production by Human Synovial Cells and Dermal , 2022 .

[27]  L. Gordon,et al.  Regulation of erythroid colony formation by bone marrow macrophages. , 1980, Blood.